Switch to:
More From Other Websites
Final Glance: Pharmaceuticals companies Mar 02 2015
Bristol-Myers Squibb Announces Dividend Mar 02 2015
Midday Glance: Pharmaceuticals companies Mar 02 2015
ALLY Trial Demonstrates 97% Hepatitis C Cure Rates Among Patients Coinfected with HIV After... Mar 02 2015
U.S. Food and Drug Administration Accepts Supplemental Biologics License Application for Yervoy®... Mar 02 2015
[$$] Biotech Sector Addicted to M&A Drug Feb 27 2015
U.S. Food and Drug Administration Accepts Biologics Licensing Application for Opdivo (nivolumab) for... Feb 27 2015
U.S. Food and Drug Administration Accepts Biologics Licensing Application for Opdivo (nivolumab) for... Feb 27 2015
Early Glance: Pharmaceuticals companies Feb 27 2015
5 Top-Heavy Stocks to Sell: Oracle, Michael Kors and More Feb 27 2015
Bristol-Myers: Drug combo cured hepatitis C in 97% with HIV Feb 26 2015
Study of Next-Generation Investigational HIV-1 Maturation Inhibitor Shows Positive Results in... Feb 26 2015
ALLY Trial Demonstrates 97% Hepatitis C Cure Rates Among Patients Coinfected with HIV After... Feb 26 2015
Bristol hep C drug helps cure 97 pct of HIV coinfected patients-study Feb 26 2015
Rigel Pharma CEO pulls back the curtain on drug deal with Bristol-Myers Feb 26 2015
Exchange-traded funds that hold big pharma Feb 26 2015
Study of Next-Generation Investigational HIV-1 Maturation Inhibitor Shows Positive Results in... Feb 26 2015
How to arrive at valuations for big pharma Feb 25 2015
Bristol-Myers Squibb Launches Phase III Trial Of HIV Drug Feb 25 2015
Eight Undervalued Key Antibiotics Players Feb 25 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK